Novo Nordisk shares jump 7.5%Â after US approves weight-loss pill
Novo Nordisk shares jump 7.5%Â after US approves weight-loss pill
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
L1 Capital, an investment management firm, released its "L1 Capital International Fund" (unhedged) fourth-quarter 2025 investor letter. A copy of the lette...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Novo Nordisk shares jump 7.5%Â after US approves weight-loss pill
FDA awards priority vouchers to two investigational drugs
Here's how the next generation of obesity drugs getting closer to patients differs from Wegovy and Zepbound
Eli Lilly and Novo Nordisk file their new weight-loss drugs with the FDA.
Exclusive-US FDA taps Merck drugs with blockbuster sales potential for national priority vouchers
Eli Lilly’s “triple g” drug helped patients lose about 28.7% of their body weight while also reducing pain associated with knee osteoarthritis in a Phase 3 tria... | Source: www.ma...